Dr. Nicolls is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1701 Page Mill Road
Palo Alto, CA 94304Phone+1 650-862-7158Fax+1 650-723-0074
Summary
- Dr. Mark Nicolls is a pulmonologist in Palo Alto, CA and is affiliated with multiple hospitals in the area, including Stanford Health Care and VA Palo Alto Health Care System. He received his medical degree from Stanford University School of Medicine and has been in practice 24 years. He specializes in lung transplantation medicine, pleural disease, and pulmonary vascular medicine and is experienced in transplant pulmonology, lung transplantation, critical care medicine, bronchiolitis obliterans, lymphatic disease, and general pulmonology.
Education & Training
- University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 2000
- Stanford University School of MedicineClass of 1993
Certifications & Licensure
- CA State Medical License 2007 - 2026
- CO State Medical License 1997 - 2009
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Association of American Physicians 2020
- American Society for Clinical Investigation 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
Publications & Presentations
PubMed
- 10 citationsExploring disease interrelationships in patients with lymphatic disorders: A single center retrospective experience.Stanley G Rockson, Xin Zhou, Lan Zhao, Davood K Hosseini, Xinguo Jiang
Clinical and Translational Medicine. 2022-04-01 - 50 citationsSafety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind,...Roham T. Zamanian, David B. Badesch, Lorinda Chung, Robyn T. Domsic, Thomas A. Medsger
American Journal of Respiratory and Critical Care Medicine. 2021-03-02 - 33 citationsLeukotrienes in Tumor-Associated Inflammation.Wen Tian, Xinguo Jiang, Dongeon Kim, Torrey Guan, Mark R. Nicolls
Frontiers in Pharmacology. 2020-08-19
Press Mentions
- Breathing Current Bay Area Air Compares to Smoking '8 Cigarettes,' Health Expert SaysSeptember 15th, 2020
- Inflammation Triggers Silent Mutation to Cause Deadly Lung DiseaseAugust 29th, 2019
- Anti-Inflammatory Drug Effective for Treating Lymphedema SymptomsOctober 18th, 2018
- Join now to see all
Grant Support
- A Critical Role For The Microvasculature In Airway TransplantationNational Heart, Lung, And Blood Institute2010–2012
- The Role Of Complement In Airway Microvascular DiseaseVeterans Affairs2011
- Elafin To Prevent Acute Rejection Following Lung TransplantationNational Heart, Lung, And Blood Institute2011
- An Autoimmune Basis For Pulmonary Hypertension.National Heart, Lung, And Blood Institute2007–2009
- An Autoimmune Basis For Pulmonary Hypertension.National Heart, Lung, And Blood Institute2006
- Viability Assay For Human Islet TransplantationNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
- Mechanisms Of Allograft ToleranceNational Institute Of Diabetes And Digestive And Kidney Diseases2003
- Mechanisms Of Allograft ToleranceNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: